Navigation Links
New Report Just Published: World Prostate Cancer Therapeutics Market Report
Date:7/7/2009

Table 3: New Cancer Cases Diagnosed in the US in 2007: Percentage Share by Leading Cancer Sites (includes corresponding Graph/Chart) II-7 Demographics & Lifestyles Raise the Risk of Prostate Cancer II-7 Table 4: Probability of Developing Invasive Prostate Cancer by Age Group in the US (includes corresponding Graph/Chart) II-7 Table 5: Male Population by Age Group in the US for the year 2007 (includes corresponding Graph/Chart) II-8 Select General Risk Factors and their Relative Risk Rate in Prostate Cancer II-8 Unmet Needs Leave Scope for Further Research and Development II-8 Supportive Cancer Drugs Contribute to Growth II-8 Select FDA Approved Drugs for Palliative Treatment of Advanced Prostate Cancer II-9 Improved Screening, Diagnosis & Patient Survival Rates Trigger Growth II-9 Table 6: Five-Year Prostate Cancer Survival Rate in the US by Race, 1975-2002 (includes corresponding Graph/Chart) II-9 Table 7: Five-Year Cancer Survival Rate Among US Males by Type - Prostate and Testis (1996-2002) (includes corresponding Graph/Chart) II-10 Table 8: Five-Year Cancer Survival Rate (%) in the US by Race, 1996-2003 (includes corresponding Graph/Chart) II-10 Molecular Imaging of Cancer: Critical in Improving Patient Outcomes II-11 Growth Restraints II-11 Limited Tumor Specificity and Toxicity II-11 Complicated Treatment Protocols: A Major Stumbling Block in Patient Compliance II-11 Multiple Drug Resistance II-12 Stringent Regulations Delay Market Approval II-12 Ongoing Clinical Trials in Hormone Refractory Prostate Cancer II-12 Challenges Encountered in Clinical Trials II-12 Notable Prostate Cancer Drug Failures in Phase III Development II-13 High Development Costs Retracts Manufacturers in Developing Countries II-13 2. Clinical Trials II-14 Drugs in Pipeline II-14
'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. QMed, Inc. Reports July Medicare SNP Enrollments
3. Phlo Affiliate Reports Expanded Coverage to Oregon Border
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
6. Carrington Reports Second Quarter 2007 Results
7. Avitar Reports Third Quarter Financial Results for Fiscal 2007
8. Response Genetics Reports Second Quarter 2007 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Transgenomic, Inc. Reports Second Quarter 2007 Results
11. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Franklin, MA (PRWEB) September 17, 2014 ... pre-engineered version of its TerraPure tank . This ... tanks is molded from FDA-compliant linear polyethylene and available ... seven pre-installed fittings and ships in two weeks or ... same features and benefits found in Terracon’s existing TerraPure ...
(Date:9/17/2014)... SAN FRANCISCO, Calif. , Sept. 17, 2014 /PRNewswire/ ... ), a molecular diagnostics company pioneering the field of ... Hall to chief operating officer. Mr. Hall ... spearhead the company,s commercial entry into endocrinology. Since 2012, ... operations, as well as managed care and billing functions. ...
(Date:9/17/2014)... 17, 2014 First ... from a truly novel class of anti-infective ... Biopharma, a biopharmaceutical company developing a truly ... it has secured £4.0m ($6.4m) to advance ... against a range of Gram-positive infections including  ...
(Date:9/16/2014)... Sept. 16, 2014 This report analyzes the worldwide ... Segments: Software, Hardware, and Biocontent. The report provides separate comprehensive ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. Market data and analytics ...
Breaking Biology Technology:Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7Global Bioinformatics Industry 2Global Bioinformatics Industry 3Global Bioinformatics Industry 4Global Bioinformatics Industry 5Global Bioinformatics Industry 6Global Bioinformatics Industry 7Global Bioinformatics Industry 8Global Bioinformatics Industry 9Global Bioinformatics Industry 10Global Bioinformatics Industry 11Global Bioinformatics Industry 12Global Bioinformatics Industry 13Global Bioinformatics Industry 14Global Bioinformatics Industry 15Global Bioinformatics Industry 16Global Bioinformatics Industry 17Global Bioinformatics Industry 18Global Bioinformatics Industry 19Global Bioinformatics Industry 20Global Bioinformatics Industry 21Global Bioinformatics Industry 22Global Bioinformatics Industry 23
... , , , For quantitative, real-time PCR and two-step RT-PCR using sequence-specific , probes, , ... , Component, Included, ... , , , ... Yes, 2x premixed solution*, , ...
... , , , , For ... , , , , , , ... all reverse transcription with any amount of RNA from 50 ng to 2 ... higher sensitivity and , superior performance even with low copy numbers ...
... , , , , , ... of 139 human cancer-related genes for functional genomics research using , ... , , , , , , ... cancer researchers (see table below for a list of genes). Every siRNA ...
Cached Biology Technology:Cancer siRNA Oligo Set Version 1.0 2Cancer siRNA Oligo Set Version 1.0 3Cancer siRNA Oligo Set Version 1.0 4
(Date:9/17/2014)... plastic shopping bags and their environmental impact recently scored ... first statewide ban on the bags, and Governor Jerry ... bag industry is not yielding without a fight, according ... , the weekly newsmagazine of the American Chemical Society. ... that the anti-bag campaign logged its first small victory ...
(Date:9/17/2014)... have obtained the first partial genome sequence of an ... at the site of the Montsoriu Castle in Girona, ... closely related to today,s Iberian pig. Researchers also discard ... Iberian pigs. , The study, published in Heredity ... species, and particularly on that of the Iberian breed, ...
(Date:9/17/2014)... Researchers at UTSouthwestern Medical Center have found that the ... called apoE3, helps repair the lining of blood vessels. ... the benefit of this repair, putting them at higher ... have identified one mechanism by which apoE3 promotes a ... is detrimental," said Dr. Philip Shaul , Professor ...
Breaking Biology News(10 mins):Iberian pig genome remains unchanged after 5 centuries 2Protein variant may boost cardiovascular risk by hindering blood vessel repair 2
... German . , Research has not proven that the ... off using contraceptive pills because this has been listed ... be narrowing their contraceptive choices without good reason, according ... Health Care (IQWiG). Different forms of contraception have other ...
... around 12 months of age, their brains actually begin ... by the time they start talking, babies actually already ... infants can be a challenging endeavor, researchers have begun ... what infants learn, according to a new report by ...
... Georgetown University Medical Center have discovered a novel way ... the world,s largest-selling breast cancer prevention and treatment drug. ... identify tamoxifen users who are no longer benefiting from ... sooner. , In the November 1 issue of the ...
Cached Biology News:Research shows that the pill does not deserve its reputation for causing weight gain 2Baby talk: The roots of the early vocabulary in infants' learning from speech 2Baby talk: The roots of the early vocabulary in infants' learning from speech 3'New' estrogen receptor found to be key player in tamoxifen resistance 2'New' estrogen receptor found to be key player in tamoxifen resistance 3
Request Info...
Limit of detection: <5 pg/ml...
Request Info...
... the premium quality siRNAs you need for ... be readily ordered online by providing either ... providing the sense and antisense siRNA sequences. ... Silencer Pre-designed siRNAs, which are already designed ...
Biology Products: